Mednax Inc (MD) Gets a Hold Rating from Stifel Nicolaus


In a report released today, Chad Vanacore from Stifel Nicolaus reiterated a Hold rating on Mednax Inc (NYSE: MD), with a price target of $47. The company’s shares opened today at $42.60, close to its 52-week low of $40.56.

According to TipRanks.com, Vanacore is ranked #2699 out of 4839 analysts.

Mednax Inc has an analyst consensus of Hold, with a price target consensus of $48.40, representing a 13.6% upside. In a report issued on July 18, Jefferies also reiterated a Hold rating on the stock with a $48 price target.

.

See today’s analyst top recommended stocks >>

The company has a one-year high of $63.04 and a one-year low of $40.56. Currently, Mednax Inc has an average volume of 742.2K.

Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is neutral on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts